Walleye Capital’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-303,246
| Closed | -$876K | – | 6077 |
|
|
2024
Q2 | $876K | Sell |
303,246
-36,000
| -11% | -$85K | ﹤0.01% | 2986 |
|
|
2024
Q1 | $729K | Sell |
339,246
-669,149
| -66% | -$1.32M | ﹤0.01% | 2878 |
|
|
2023
Q4 | $1.58M | Buy |
1,008,395
+316,160
| +46% | +$371K | ﹤0.01% | 1971 |
|
|
2023
Q3 | $879K | Buy |
692,235
+326,772
| +89% | +$416K | ﹤0.01% | 2350 |
|
|
2023
Q2 | $453K | Sell |
365,463
-85,877
| -19% | -$76.4K | ﹤0.01% | 2516 |
|
|
2023
Q1 | $388K | Sell |
451,340
-274,078
| -38% | -$232K | 0.01% | 1912 |
|
|
2022
Q4 | $448K | Buy |
725,418
+26,861
| +4% | +$18K | 0.01% | 1525 |
|
|
2022
Q3 | $454K | Sell |
698,557
-9,897
| -1% | -$8.01K | 0.01% | 1546 |
|
|
2022
Q2 | $548K | Buy |
708,454
+169,924
| +32% | +$155K | 0.02% | 974 |
|
|
2022
Q1 | $684K | Buy |
538,530
+504,766
| +1,495% | +$637K | 0.02% | 827 |
|
|
2021
Q4 | $59K | Buy |
33,764
+23,480
| +228% | +$52K | ﹤0.01% | 1761 |
|
|
2021
Q3 | $22 | Buy |
+10,284
| New | +$23.7K | ﹤0.01% | 1482 |
|
Walleye Capital's CLBTW Position: Q3 2024 in Review
Walleye Capital sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q3 2024, closing a stake of 303,246 shares — an estimated $876K sold.
Walleye Capital first reported a position in CLBTW in Q3 2021 and held it in 12 quarters. The position peaked at $1.58M in Q4 2023. 0 funds tracked by Wall St. Rank hold CLBTW as of Q3 2024.
- Walleye Capital reported no remaining Cellebrite DI Ltd. Warrants position as of Q3 2024 after selling out during the quarter.
- Walleye Capital sold 303,246 Cellebrite DI Ltd. Warrants shares in Q3 2024, an estimated $876K.
- Walleye Capital first reported a position in Cellebrite DI Ltd. Warrants in Q3 2021 and held it in 12 quarters.
- Walleye Capital's Cellebrite DI Ltd. Warrants position peaked at $1.58M in Q4 2023.
- 0 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q3 2024.
Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.